New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Quest Diagnostics Incorporated
DGX
Shape
US Flag

NYSE

20B

Medical - Diagnostics & Research

Next Earning date - 22 Jul 2025

20B

Medical - Diagnostics & Research

Next Earning date - 22 Jul 2025

178.22USD

Shape-0.28 ( -0.15%)
moonAfter-hours 177.19$arrow-left-down-1.03 (-0.58%)
Market Closed (as of Apr 30, 19:59 EDT)
favorite-chart

Relative Strenght

91
favorite-chart

Volume Buzz

-2%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated April 30, 2025
1W 1.34 % 1M 5.85 % 3M 9.81 % 1Y 32.19 %

Key Metrics

Shape
  • Market Cap

    19.90B


  • Shares Outstanding

    111.64M


  • Share in Float

    111.06M


  • Dividende

    3.05


  • Earning Date

    22 Jul 2025


  • Price Target

    178.225


  • Average Volume

    1.32M


  • Beta

    0.776


  • Range

    135.26-179.16


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.questdiagnostics.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

DGX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$11B

Shape324%

2026-Revenue

$10.54

Shape435%

2026-EPS

$3B

Shape412%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

186.50(4.64%)

Number of analyst

4

Last analyst upgrade/downgrade

Citigroup

downgrade

Previous: Buy

2025-03-04

Now: Neutral

Citigroup

upgrade

Previous: Neutral

2024-07-10

Now: Buy

Morgan Stanley

downgrade

Previous: Equal-Weight

2023-04-03

Now: Underweight

Goldman Sachs

upgrade

Previous: Not converted

2023-04-03

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-3%

2.3
vs 2.36

Q3.23

arrow
arrow

-6%

2.22
vs 2.36

Q4.23

arrow
arrow

+9%

2.15
vs 1.98

Q1.24

arrow
arrow

N/A

2.04
vs 2.04

Q2.24

arrow
arrow

+2%

2.35
vs 2.3

Q3.24

arrow
arrow

+4%

2.3
vs 2.22

Q4.24

arrow
arrow

+4%

2.23
vs 2.15

Q1.25

arrow
arrow

+8%

2.21
vs 2.04

Q2.25

arrow
arrow

+9%

2.57
vs 2.35

Q3.25

arrow
arrow

+9%

2.51
vs 2.3

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

-5%

2.3B  vs 2.5B

Q3.23

arrow
arrow

-8%

2.3B  vs 2.5B

Q4.23

arrow
arrow

-2%

2.3B  vs 2.3B

Q1.24

arrow
arrow

+2%

2.4B  vs 2.3B

Q2.24

arrow
arrow

+3%

2.4B  vs 2.3B

Q3.24

arrow
arrow

+8%

2.5B  vs 2.3B

Q4.24

arrow
arrow

+15%

2.6B  vs 2.3B

Q1.25

arrow
arrow

+12%

2.7B  vs 2.4B

Q2.25

arrow
arrow

+14%

2.7B  vs 2.4B

Q3.25

arrow
arrow

+9%

2.7B  vs 2.5B

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

+4%

0.04
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.04

Q4.23

arrow
arrow

+3%

0.03
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Q3.24

arrow
arrow

+3%

0.03
vs 0.03

Q4.24

arrow
arrow

+3%

0.03
vs 0.03

Q1.25

arrow
arrow

+3%

0.03
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

849

849
vs 903

-6%

Q2.23

arrow
arrow

836

836
vs 849

-2%

Q3.23

arrow
arrow

819

819
vs 836

-2%

Q4.23

arrow
arrow

846

846
vs 819

3%

Q1.24

arrow
arrow

830

830
vs 846

-2%

Q2.24

arrow
arrow

852

852
vs 830

3%

Q3.24

arrow
arrow

860

860
vs 852

1%

Q4.24

arrow
arrow

900

900
vs 860

5%

Earnings Growth

Latest News